ESC 365 - Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: Final results from the INSPIRATION randomized trial

EAPC Premium Access

Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: Final results from the INSPIRATION randomized trial

Session: Late-Breaking Science: be the first to know!

Topic: Treatment

Speaker: Professor P. Sadeghipour (Tehran, IR)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Professor Parham Sadeghipour

Rajaie Cardiovascular Medical & Research Center, Tehran (Iran (Islamic Republic of))

6 presentations

0 follower

5 more presentations in this session

Effectiveness of an ambulatory virtual cardiac rehabilitation program versus traditional cardiac rehabilitation: a randomized controlled study.

Speaker: Doctor J. Gomez Polo (Madrid, ES)

Cytochrome P450 polymorphisms and left ventricular failure following percutaneous coronary intervention

Speaker: Professor N. Abdelmoula (Sfax, TN)

Effect of Icosapent Ethyl on Changes in Coronary Plaque Morphology: EVAPORATE

Speaker: Mr A. Buckler (Stockholm, SE)

The hypotensive effects of home-based isometric handgrip training in older adults with pre-hypertension and hypertension

Speaker: Mr D. Pinto (Maia, PT)

Late-Breaking Science: be the first to know! Discussion.

Access the full session

Late-Breaking Science: be the first to know!

Speakers: Professor P. Sadeghipour, Doctor J. Gomez Polo, Professor N. Abdelmoula, Mr A. Buckler, Mr D. Pinto

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources